Bain Capital Life Sciences Investors, LLC

Q1 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    24

  • Value ($000)

    $675,913

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$219.42M
33 %

10,719,110

NUVL
NUVL

NUVALENT INC

COM
670703107
$102.64M
15 %

1,447,267

---

PHARVARIS N V

COM
N69605108
$51.86M
8 %

3,303,381

IRON
IRON

DISC MEDICINE INC

COM
254604101
$48.82M
7 %

983,500

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$48.79M
7 %

2,689,707

YB4P
YB4P

SAVARA INC

COM
805111101
$48.75M
7 %

17,600,621

---

SOLID BIOSCIENCES INC

COM NEW
83422E204
$29.27M
4 %

7,911,669

OLMA
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$25.73M
4 %

6,843,954

RPID
RPID

RAPID MICRO BIOSYSTEMS INC

CLASS A COM
75340L104
$22.27M
3 %

8,434,560

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
171757206
$15.14M
2 %

703,080

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 24